These compounds, MDMA, psilocybin, and IOSCA are being studied for treatment-resistant depression, opiate addiction, nicotine addiction, and to treat people with PTSD that has been unresponsive to treatments for 15 to 20 years, and other conditions as they elicit openness, compassion, decreased fear response, self-empathy, being a generator of empathy in humans.